SK118498A3 - Novel erythromycin derivatives, method for preparing same, and use thereof as drugs - Google Patents

Novel erythromycin derivatives, method for preparing same, and use thereof as drugs Download PDF

Info

Publication number
SK118498A3
SK118498A3 SK1184-98A SK118498A SK118498A3 SK 118498 A3 SK118498 A3 SK 118498A3 SK 118498 A SK118498 A SK 118498A SK 118498 A3 SK118498 A3 SK 118498A3
Authority
SK
Slovakia
Prior art keywords
formula
compounds
group
methyl
dideoxy
Prior art date
Application number
SK1184-98A
Other languages
English (en)
Slovak (sk)
Inventor
Constantin Agouridas
Jean-Francois Chantot
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of SK118498A3 publication Critical patent/SK118498A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK1184-98A 1996-02-28 1997-02-27 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs SK118498A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
SK118498A3 true SK118498A3 (en) 1999-07-12

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1184-98A SK118498A3 (en) 1996-02-28 1997-02-27 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs

Country Status (31)

Country Link
US (1) US6096714A (de)
EP (1) EP0885234B1 (de)
JP (1) JP4102440B2 (de)
KR (1) KR100486053B1 (de)
CN (1) CN1168734C (de)
AP (1) AP952A (de)
AR (1) AR005999A1 (de)
AT (1) ATE217633T1 (de)
AU (1) AU716204B2 (de)
BG (1) BG63207B1 (de)
BR (1) BR9707709B1 (de)
CZ (1) CZ293893B6 (de)
DE (1) DE69712610T2 (de)
DK (1) DK0885234T3 (de)
EA (1) EA001376B1 (de)
EE (1) EE9800265A (de)
ES (1) ES2176698T3 (de)
FR (1) FR2745290B1 (de)
HU (1) HU227567B1 (de)
IL (1) IL125622A (de)
NO (1) NO983955L (de)
NZ (1) NZ331600A (de)
OA (1) OA10845A (de)
PL (1) PL191736B1 (de)
PT (1) PT885234E (de)
SK (1) SK118498A3 (de)
TR (1) TR199801713T2 (de)
UA (1) UA58504C2 (de)
WO (1) WO1997031929A1 (de)
YU (1) YU37098A (de)
ZA (1) ZA971659B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンａ誘導体
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
WO2000044761A2 (en) 1999-01-27 2000-08-03 Pfizer Products Inc. Ketolide antibiotics
CZ20013733A3 (cs) * 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
AU6183700A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010880A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (de) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP2772254A3 (de) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Neuartige antibakterielle Mittel
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CN101917850B (zh) * 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
CN108570083A (zh) 2010-03-22 2018-09-25 森普拉制药公司 大环内脂的结晶形式及其用途
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (de) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von atemwegserkrankungen und formulierungen dafür
EP2968384A4 (de) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Konvergente verfahren zur herstellung antibakterieller makrolidmittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK0885234T3 (da) 2002-08-26
PL191736B1 (pl) 2006-06-30
NO983955D0 (no) 1998-08-27
WO1997031929A1 (fr) 1997-09-04
EA001376B1 (ru) 2001-02-26
KR19990087324A (ko) 1999-12-27
ATE217633T1 (de) 2002-06-15
AP9801318A0 (en) 1998-09-30
HUP9902576A1 (hu) 1999-12-28
CZ293893B6 (cs) 2004-08-18
EA199800768A1 (ru) 1999-02-25
AP952A (en) 2001-03-29
TR199801713T2 (xx) 1998-12-21
US6096714A (en) 2000-08-01
ZA971659B (en) 1998-02-26
NO983955L (no) 1998-08-27
EP0885234A1 (de) 1998-12-23
BR9707709A (pt) 1999-04-06
AU716204B2 (en) 2000-02-24
IL125622A (en) 2003-10-31
CN1212700A (zh) 1999-03-31
FR2745290B1 (fr) 1998-04-03
DE69712610T2 (de) 2002-11-28
AU1929897A (en) 1997-09-16
YU37098A (sh) 1999-07-28
NZ331600A (en) 1999-08-30
FR2745290A1 (fr) 1997-08-29
EE9800265A (et) 1999-02-15
BR9707709B1 (pt) 2014-10-14
AR005999A1 (es) 1999-07-21
KR100486053B1 (ko) 2005-06-16
BG102691A (en) 1999-06-30
JP2000505469A (ja) 2000-05-09
OA10845A (fr) 2003-02-05
DE69712610D1 (de) 2002-06-20
BG63207B1 (bg) 2001-06-29
ES2176698T3 (es) 2002-12-01
PT885234E (pt) 2002-10-31
PL328608A1 (en) 1999-02-01
JP4102440B2 (ja) 2008-06-18
UA58504C2 (uk) 2003-08-15
EP0885234B1 (de) 2002-05-15
CZ258798A3 (cs) 1998-12-16
CN1168734C (zh) 2004-09-29
IL125622A0 (en) 1999-04-11
HU227567B1 (en) 2011-08-29
HUP9902576A3 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
SK118498A3 (en) Novel erythromycin derivatives, method for preparing same, and use thereof as drugs
JP3130097B2 (ja) 新規なエリスロマイシン誘導体、その製造法、得られる新規な中間体及びそれらの薬剤としての使用
JP3140703B2 (ja) 新規なエリスロマイシン、それらの製造法及び薬剤としての用途
AU697876B2 (en) New erythromycin derivatives, their preparation process and their use as medicaments
JPH06199887A (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
JP4573925B2 (ja) 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
JP5188520B2 (ja) 新規なエリスロマイシン誘導体、製造方法及び医薬としての利用
AP997A (en) Novel erythromycin derivatives, method for preparing them and their use as medicine.
AP1078A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs.
JP2001513101A (ja) 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
JP4864184B2 (ja) ５−デスオサミニルエリスロノリドａの新規の２−ハロゲン化誘導体、それらの製造方法及び薬剤としてのそれらの使用
USRE38520E1 (en) Erythromycin derivatives, method for preparing same, and use thereof as drugs
AU761551B2 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
MXPA99005226A (en) Novel erythromycin derivatives, method for preparing them and their use as medicine
MXPA99005840A (en) Novel erythromycin derivatives, method of preparation and application as medicines